Kits Eyecare Valuation
| KITS Stock | CAD 9.19 0.34 3.84% |
At this time, the firm appears to be undervalued. Kits Eyecare secures a last-minute Real Value of C$10.09 per share. The latest price of the firm is C$9.19. Our model forecasts the value of Kits Eyecare from analyzing the firm fundamentals such as Return On Equity of -0.002, profit margin of (0.0007) %, and Current Valuation of 283.99 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Kits Eyecare's valuation include:
Price Book 5.4423 | Enterprise Value 284 M | Enterprise Value Ebitda 68.2184 | Price Sales 1.9853 | Forward PE 65.7895 |
Undervalued
Today
Please note that Kits Eyecare's price fluctuation is not too volatile at this time. Calculation of the real value of Kits Eyecare is based on 3 months time horizon. Increasing Kits Eyecare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Kits Eyecare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Kits Stock. However, Kits Eyecare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 9.19 | Real 10.09 | Hype 9.17 |
The intrinsic value of Kits Eyecare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Kits Eyecare's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Kits Eyecare helps investors to forecast how Kits stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Kits Eyecare more accurately as focusing exclusively on Kits Eyecare's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Kits Eyecare's intrinsic value based on its ongoing forecasts of Kits Eyecare's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Kits Eyecare's closest peers.
Kits Eyecare Cash |
|
Kits Valuation Trend
Knowing Kits Eyecare's actual value is paramount for traders when making sound investment determinations. Using both Kits Eyecare's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Kits Eyecare Total Value Analysis
Kits Eyecare is now estimated to have takeover price of 283.99 M with market capitalization of 290.19 M, debt of 15.39 M, and cash on hands of 18.79 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Kits Eyecare fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
283.99 M | 290.19 M | 15.39 M | 18.79 M |
Kits Eyecare Investor Information
About 76.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.01. Kits Eyecare had not issued any dividends in recent years. The entity had 3:2 split on the 14th of May 2007. Based on the measurements of operating efficiency obtained from Kits Eyecare's historical financial statements, Kits Eyecare is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Kits Eyecare Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The recent return on assets of Kits suggests not a very effective usage of assets in December.Kits Eyecare Ownership Allocation
Kits Eyecare maintains a total of 31.58 Million outstanding shares. Kits Eyecare secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 75.76 % of Kits Eyecare outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Kits Eyecare Profitability Analysis
The company reported the revenue of 120.51 M. Net Loss for the year was (2.21 M) with profit before overhead, payroll, taxes, and interest of 29.25 M.About Kits Eyecare Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Kits Eyecare. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Kits Eyecare based exclusively on its fundamental and basic technical indicators. By analyzing Kits Eyecare's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Kits Eyecare's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Kits Eyecare. We calculate exposure to Kits Eyecare's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Kits Eyecare's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 40.8 M | 23.3 M | |
| Pretax Profit Margin | (0.02) | (0.03) | |
| Operating Profit Margin | (0.02) | (0.02) | |
| Net Loss | (0.02) | (0.02) | |
| Gross Profit Margin | 0.34 | 0.24 |
Other Information on Investing in Kits Stock
Kits Eyecare financial ratios help investors to determine whether Kits Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kits with respect to the benefits of owning Kits Eyecare security.